TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Efficacy and Safety of Switching to Daily Bictegravir Plus Lenacapavir From a Complex HIV Treatment Regimen: A Randomized, Open-Label, Multicenter Phase 2 Study (ARTISTRY-1).

Karam Mounzer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.